Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022
Landec Corporation (Nasdaq: LNDC) announced a fireside chat featuring CEO Jim Hall and CFO John Morberg at the Stephens Annual Investment Conference in Nashville, TN, scheduled for November 17 at 8:00 AM CT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Landec Corporation (Nasdaq: LNDC) announced a fireside chat featuring CEO Jim Hall and CFO John Morberg at the Stephens Annual Investment Conference in Nashville, TN, scheduled for November 17 at 8:00 AM CT. The event will be available via live audio webcast on the company's investor relations website. Landec operates through two segments: Lifecore Biomedical and Curation Foods, with Lifecore specializing in contract development and manufacturing of sterile injectable products.
Details
News Market Reaction – LNDC
The recorded move for LNDC in the trading session of this news was +4.39%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHASKA, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. (“Lifecore”) and Curation Foods, Inc. (“Curation Foods”), – today announced that Jim Hall, CEO of Landec Corporation & President of Lifecore, and John Morberg, CFO will be hosting a fireside chat at the Stephens Annual Investment Conference in Nashville, TN.
The Company will participate in a fireside chat on Thursday, November 17th at 8:00 AM CT. The live audio webcast will be available to all interested parties through a live audio webcast accessible on the Company's investor relations website at https://ir.landec.com/.
About Lifecore Biomedical
Lifecore Biomedical (Nasdaq: LNDC) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the Company, visit Lifecore’s website at www.lifecore.com.
Landec Corp. Contact Information:
Investor Relations
Jeff Sonnek
(646) 277-1263
jeff.sonnek@icrinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.